Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
CNY 57.39
(-0.92%)
CNY 57.39
(-0.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 574.33 Million | 194.99 Million | 130.32 Million | 369.56 Million | 182.72 Million | 57.35 Million |
| Net Income | 509.21 Million | 598.06 Million | 829.47 Million | 408.04 Million | 186.68 Million | 154.13 Million |
| Depreciation & Amortization | 61.77 Million | 32.57 Million | 16.53 Million | 12.26 Million | 9.07 Million | 9.33 Million |
| Deferred income taxes | -1.45 Million | 6.27 Million | -1.85 Million | 123.36 Thousand | 337.09 Thousand | -240.1 Thousand |
| Stock-based compensation | -3.95 Million | 1.85 Million | 8.9 Million | 10.76 Million | 18.66 Million | 21.87 Million |
| Change in working capital | -39.66 Million | -438.14 Million | -469.9 Million | -61.59 Million | -37.07 Million | -137.34 Million |
| Other non-cash items | 207.66 Million | 2.49 Million | -245.78 Million | 10.84 Million | 24.03 Million | 31.21 Million |
| Investing Cash Flow | -163.73 Million | -412.45 Million | -201.52 Million | -441.39 Million | -23.96 Million | -34.57 Million |
| Investments in PPE | -157.27 Million | -419.22 Million | -314.93 Million | -135.66 Million | -24.03 Million | -34.58 Million |
| Acquisitions | 36.59 Thousand | 1568.00 | 10 Thousand | 135.71 Million | 66.09 Thousand | 3922.33 |
| Investment purchases | -56.5 Million | -210 Million | -850.25 Million | -592.5 Million | - | - |
| Sales/Maturities of investments | 50 Million | 216.76 Million | 963.65 Million | 286.72 Million | - | - |
| Other Investing Activities | -6.11 Million | 0.58 | 0.11 | -135.66 Million | 0.26 | 3922.33 |
| Financing Cash Flow | -7.11 Million | -73.56 Million | -147.39 Million | 975.75 Million | -9.53 Million | 7 Million |
| Debt repayment | -64.82 Million | -30 Million | - | -10 Million | -32.5 Million | -7.5 Million |
| Dividends payments | -66.87 Million | -133.77 Million | -90 Million | -230.79 Thousand | -532.83 Thousand | -5.94 Million |
| Common Stock Repurchased | - | -67.21 Million | -55.88 Million | -985.98 Million | - | - |
| Common Stock Issuance | - | 67.21 Million | - | 985.98 Million | - | - |
| Other Financing Activities | -4.76 Million | 93.25 Million | -1.51 Million | 985.98 Million | 23.5 Million | 20.44 Million |
| Accounts receivables | -113.84 Million | -448.9 Million | -535.22 Million | -102.15 Million | -25.86 Million | -154.05 Million |
| Accounts payables | 95.7 Million | 61.35 Million | 124.71 Million | 41.69 Million | 4.48 Million | 23.28 Million |
| Inventory | -21.52 Million | -56.85 Million | -57.53 Million | -1.25 Million | -16.03 Million | -6.33 Million |
| Other working capital | -3.95 Million | 6.27 Million | -1.85 Million | 123.36 Thousand | 337.09 Thousand | -131 Million |
| Cash at beginning of period | 651.46 Million | 926.87 Million | 1.14 Billion | 241.63 Million | 92.35 Million | 62.57 Million |
| Cash at end of period | 1.03 Billion | 635.95 Million | 926.87 Million | 1.14 Billion | 241.63 Million | 92.35 Million |
| Capital Expenditure | -157.27 Million | -419.22 Million | -314.93 Million | -135.66 Million | -24.03 Million | -34.58 Million |
| Effect of forex changes on cash | -69.07 Thousand | 112.98 Thousand | -13.55 Thousand | -62.18 Thousand | 48.58 Thousand | -626.89 |
| Net cash flow / Change in cash | 387.9 Million | -290.92 Million | -218.61 Million | 903.85 Million | 149.27 Million | 29.78 Million |
| Free Cash Flow | 417.05 Million | -224.23 Million | -184.61 Million | 233.89 Million | 158.69 Million | 22.77 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 157.08 Million | 149.46 Million | 140.27 Million | 509.21 Million | 120.73 Million |
| Depreciation & Amortization | - | 24.3 Million | 24.3 Million | 18.74 Million | 61.77 Million | 18.74 Million |
| Deferred income taxes | - | - | - | 143.27 Million | -1.45 Million | -50.57 Million |
| Stock-based compensation | - | - | - | -3.95 Million | -3.95 Million | -1.2 Million |
| Change in working capital | - | -32.96 Million | - | -139.31 Million | -39.66 Million | 51.78 Million |
| Other non-cash items | - | -54.83 Million | -50.87 Million | 150.29 Million | 207.66 Million | 3.76 Million |
| Investing Cash Flow | -39.06 Million | 29.55 Million | -85.78 Million | -51.74 Million | -163.73 Million | -27.51 Million |
| Investments in PPE | -40.34 Million | -20.44 Million | -35.78 Million | -51.77 Million | -157.27 Million | -28.91 Million |
| Acquisitions | - | - | - | 32.59 Thousand | 36.59 Thousand | - |
| Investment purchases | - | - | -100 Million | -50 Million | -56.5 Million | 1.4 Million |
| Sales/Maturities of investments | 1.27 Million | 50 Million | 50 Million | 50 Million | 50 Million | - |
| Other Investing Activities | 400.00 | 50.75 Million | -50 Million | 381.34 Thousand | -6.11 Million | 1.4 Million |
| Financing Cash Flow | -45.6 Million | -346.84 Million | -44.53 Million | 46.83 Million | -7.11 Million | -14.99 Million |
| Debt repayment | -40 Million | -33.71 Million | -19.3 Million | -48.77 Million | -64.82 Million | -13.02 Million |
| Dividends payments | -21.48 Thousand | -261.19 Million | -1.4 Million | -66.87 Million | -66.87 Million | -262.71 Thousand |
| Common Stock Repurchased | - | -114.36 Million | - | - | - | -1.4 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -85.62 Million | -313.12 Million | -63.84 Million | 65.24 Million | -4.76 Million | -1.71 Million |
| Accounts receivables | - | -12.73 Million | - | -113.84 Million | -113.84 Million | 15.24 Million |
| Accounts payables | - | - | - | - | 95.7 Million | - |
| Inventory | - | -20.22 Million | - | -21.52 Million | -21.52 Million | 37.54 Million |
| Other working capital | - | - | - | -3.95 Million | -3.95 Million | -1 Million |
| Cash at beginning of period | 770.07 Million | 1 Billion | 1.03 Billion | 750.49 Million | 651.46 Million | 634.29 Million |
| Cash at end of period | 762.34 Million | 770.07 Million | 1 Billion | 1.03 Billion | 1.03 Billion | 750.49 Million |
| Capital Expenditure | -40.34 Million | -20.44 Million | -35.78 Million | -51.77 Million | -157.27 Million | -28.91 Million |
| Effect of forex changes on cash | -191.53 Thousand | 1.58 Million | 195.14 Thousand | -34.3 Thousand | -69.07 Thousand | -33.76 Thousand |
| Net cash flow / Change in cash | -7.73 Million | -237.75 Million | -31.53 Million | 288.87 Million | 387.9 Million | 116.2 Million |
| Free Cash Flow | -40.34 Million | 57.5 Million | 62.8 Million | 257.54 Million | 417.05 Million | 114.32 Million |
ACE
MITT-PA
CHEMPLASTS
ACLN
ACESOFT
002037